CNTMF - Cansortium Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.5200
-0.0330 (-5.97%)
As of 9:41AM EST. Market open.
Stock chart is not supported by your current browser
Previous Close0.5530
Open0.5260
BidN/A x N/A
AskN/A x N/A
Day's Range0.5200 - 0.5260
52 Week Range0.3398 - 2.5000
Volume1,750
Avg. Volume30,542
Market Cap96.433M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0320
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.50
  • CNW Group

    Cansortium Announces Opening Of Its 17th Fluent™ Medical Marijuana Dispensary In Florida

    MIAMI , Nov. 18, 2019 /PRNewswire/ -- Cansortium Inc. ("Cansortium" or the "Company") (TIUM-U.CN), (CNTMF) a vertically-integrated provider of premium-quality medical cannabis operating under the Fluent ™ brand, continues to expand its Florida footprint with the November 16th opening of a new Fluent dispensary in a prime location in Jacksonville, Florida . Located in Jacksonville's Arlington neighborhood at 9510 Atlantic Boulevard, the new 3,700 square-foot Jacksonville dispensary is the Company's 17th in Florida and its second in Jacksonville .

  • PR Newswire

    Cansortium Inc. Provides Update On Strength Of Its Florida Business, Announces The Return Of Approximately 26 Million Shares By Current And Former Senior Executives And Progress On Key Growth Initiatives

    MIAMI, Nov. 6, 2019 /PRNewswire/ -- Cansortium Inc. (TIUM-U.CN) (CNTMF) ("Cansortium" or the "Company") and the recently-formed Special Committee of the Board of Directors today announced the continued strong growth of its Florida business and shared progress on the implementation of key elements of its new growth plan to attract capital and strategic operating partners to drive sustainable, profitable growth. Cansortium's Florida business, which generates the vast majority of the Company's sales, generated record monthly sales of $2.8 million in October, representing growth of 43 percent over September. The Company also highlighted that, since June 2019, when Florida legalized the sale of smokable cannabis in licensed dispensaries, Cansortium's smokable premium flower products have grown to represent more than one-third of its Florida sales.

  • Newsfile

    Cansortium Announces a Reorganization of Senior Management and its Board of Directors, Significant Cost Reductions and the Prioritization and Acceleration of Growth in the U.S. Markets, Particularly Florida

    Miami, Florida--(Newsfile Corp. - October 22, 2019) - Cansortium Inc. (CSE: TIUM.U) (OTCQB: CNTMF) ("Cansortium" or the "Company") and its Board of Directors (the "Board') have implemented a series of important corporate initiatives aimed at driving sustainable, profitable growth in the Company's core market of Florida by allocating the necessary capital to expand the number of dispensaries in the state to twenty by the end of 2019. These initiatives are also aimed at ensuring ...

  • Cansortium Inc. Announces Separation of CEO and Chairman Roles; Appoints Neal Hochberg as Chairman. Jose Hidalgo Continues as CEO to Focus Exclusively on Implementing the Company's Growth Initiatives
    CNW Group

    Cansortium Inc. Announces Separation of CEO and Chairman Roles; Appoints Neal Hochberg as Chairman. Jose Hidalgo Continues as CEO to Focus Exclusively on Implementing the Company's Growth Initiatives

    MIAMI , Oct. 15, 2019 /CNW/ - Cansortium Inc. (TIUM-U.CN) (CNTMF) ("Cansortium" or the "Company") today announced that its Board of Directors has elected independent director Neal Hochberg to serve as Non-Executive Chairman. Mr. Hochberg, a Certified Public Accountant, has a distinguished 40 year career in financial services. Recently, he was also appointed by the Supreme Court of Florida to membership on the Florida Board of Bar Examiners.

  • Cansortium Announces Opening of its 15th Fluent™ Medical Marijuana Dispensary in Florida and Plans to Have 6 Additional Open by the End of the Year
    PR Newswire

    Cansortium Announces Opening of its 15th Fluent™ Medical Marijuana Dispensary in Florida and Plans to Have 6 Additional Open by the End of the Year

    MIAMI, Sept. 9, 2019 /PRNewswire/ - Cansortium Inc. ("Cansortium" or the "Company") (CSE:TIUM), a vertically-integrated, global provider of premium-quality medical cannabis operating under the Fluent™ brand, continues to expand its Florida retail footprint with the September 9th opening of a new Fluent dispensary in a prime location in Cape Coral, FL. Cansortium's Chief Executive Officer Jose Hidalgo noted, "As one of the first five licensed operators in Florida - the state with the fastest-growing medical marijuana patient population in the U.S. – we continue to capitalize on our first-mover position, executing our growth plan by steadily expanding our dispensary network to enhance access to our premium-quality Fluent cannabis products for medical marijuana patients across the state.

  • Benzinga

    Cansortium Attributes Lower Q2 Revenue To 'Unexpected Delays,' Halves 2019 Outlook

    Cansortium achieved positive consolidated EBITDA of $1.8 million versus pro-forma EBITDA of $5.8 million in the second quarter of 2018. Consolidated adjusted EBITDA for the quarter was a loss of $2.6 million, compared to adjusted pro-forma positive EBITDA of $100,000 in the same quarter of the previous year. For the first half of 2019, the company reported consolidated revenue of $11.6 million, up by 37% from pro-forma revenue of $8.5 million in the first half of 2018.

  • Cansortium Inc. Reports Second Quarter 2019 Financial Results; Revises Full Year 2019 Outlook; Expects to Achieve Profitability in Early 2020
    CNW Group

    Cansortium Inc. Reports Second Quarter 2019 Financial Results; Revises Full Year 2019 Outlook; Expects to Achieve Profitability in Early 2020

    Cansortium Inc. Reports Second Quarter 2019 Financial Results; Revises Full Year 2019 Outlook; Expects to Achieve Profitability in Early 2020

  • Cansortium, Inc. Second Quarter Financial Results and Conference Call Scheduled for August 29
    PR Newswire

    Cansortium, Inc. Second Quarter Financial Results and Conference Call Scheduled for August 29

    MIAMI , Aug. 22, 2019 /PRNewswire/ - Cansortium Inc. (CSE:TIUM) (OTCQB: CNTMF) ("Cansortium" or the "Company"), a leading Florida -based medical cannabis company operating under the ...

  • Cansortium Commences Trading on OTCQB Venture Market, Bringing Increased Visibility and Enhanced Liquidity
    CNW Group

    Cansortium Commences Trading on OTCQB Venture Market, Bringing Increased Visibility and Enhanced Liquidity

    MIAMI, FL , Aug. 21, 2019 /CNW/ - Cansortium Inc. ("Cansortium" or the "Company") (CSE:TIUM) (CNTMF), a vertically-integrated, global provider of premium-quality medical cannabis operating under the Fluent™ brand, announced today that it will begin trading today on the OTCQB Venture Market under the ticker "CNTMF".  This is an upgrade from the Company's previous classification on the Pink Open Market. Cansortium Chief Executive Officer Jose Hidalgo emphasized, "We are very pleased to begin trading on the OTCQB Venture Market less than five months after our initial public offering on the Canadian Securities Exchange, adding valuable visibility and additional liquidity for the benefit of our shareholders. U.S.-based investors can find current financial disclosure and Real-Time Level 2 quotes for the company at www.otcmarkets.com.

  • CNW Group

    Cansortium Announces Significant Expansion of its State-of-the-Art Tampa Cultivation Facility to Support Continued Growth in Florida Medical Marijuana Market

    MIAMI, FL , Aug. 19, 2019 /CNW/ - Cansortium Inc. ("Cansortium" or the "Company") (CSE:TIUM), a vertically-integrated, global provider of premium-quality medical cannabis operating under the Fluent™ brand, announced today that it has begun growing in Phase 2 at its state-of-the-art indoor medical marijuana cultivation facility in Tampa, Florida . Cansortium Chief Executive Officer Jose Hidalgo emphasized, "This Phase 2 expansion of our Tampa cultivation facility is another important step in support of our strategy to increase our revenue-generating capacity toward our goal of achieving operating profitability. "Expanding our Florida production capacity provides us with additional supply of high-quality cannabis to process into the wide variety of Fluent-branded medical marijuana products sold through our Florida dispensary network, currently comprising 15 dispensaries in key markets, which we expect to expand to more than 30 during 2020.

  • Cansortium Announces Opening of its Second Fluent™ Medical Marijuana Dispensary in Puerto Rico
    PR Newswire

    Cansortium Announces Opening of its Second Fluent™ Medical Marijuana Dispensary in Puerto Rico

    MIAMI, FL, Aug. 12, 2019 /PRNewswire/ - Cansortium Inc. ("Cansortium" or the "Company") (CSE:TIUM), a vertically-integrated, global provider of premium-quality medical cannabis operating under the Fluent™ brand, continues to expand its global retail footprint with the July 25 opening of a new Fluent dispensary in a prime location at the San Patricio Town Center in Calle Tabonuco, Guaynabo, Puerto Rico. Cansortium's Chief Executive Officer Jose Hidalgo noted, "The opening of our second Fluent dispensary in Puerto Rico is further evidence that we are executing our growth plan by steadily expanding our dispensary network to enhance access to our premium-quality Fluent cannabis products for medical marijuana patients in key markets.

  • Cansortium Announces Opening of its 14th Fluent™ Medical Marijuana Dispensary in Florida
    PR Newswire

    Cansortium Announces Opening of its 14th Fluent™ Medical Marijuana Dispensary in Florida

    MIAMI, FL, Aug. 7, 2019 /PRNewswire/ - Cansortium Inc. ("Cansortium" or the "Company") (CSE:TIUM), a vertically-integrated, global provider of premium-quality medical cannabis operating under the Fluent™ brand, continues to expand its Florida retail footprint with the August 1 opening of a new Fluent dispensary in a prime location in New Port Richey, FL. Cansortium's Chief Executive Officer Jose Hidalgo noted, "As one of the first five licensed operators in Florida - the state with the fastest-growing medical marijuana patient population in the U.S. – we continue to capitalize on our first-mover position, executing our growth plan by steadily expanding our dispensary network to enhance access to our premium-quality Fluent cannabis products for medical marijuana patients across the state.

  • Cansortium Announces Opening of its Newest Fluent™ Medical Marijuana Dispensary in Cutler Bay, Florida
    CNW Group

    Cansortium Announces Opening of its Newest Fluent™ Medical Marijuana Dispensary in Cutler Bay, Florida

    MIAMI , July 9, 2019 /CNW/ - Cansortium Inc. ("Cansortium" or the "Company") (CSE:TIUM), a vertically-integrated, global provider of premium-quality medical cannabis operating under the Fluent™ brand, continues to expand its Florida retail footprint with the July 5 th opening of a new Fluent dispensary in a prime location in Cutler Bay, FL. The new 2,654 square-foot store, located at 11245 SW 211 Street, is the Company's twelfth in Florida , with eighteen more locations expected to be opened or secured by the end of 2019. The Company's dispensaries carry a complete assortment of Fluent premium dried flower, and full spectrum concentrates and cartridges as well as creams, drops, capsules and suppositories.

  • Benzinga

    Cansortium Analyst Sees 'Dramatic Expansion' Potential In Canadian Cannabis Market

    Cansortium's focus is on the medical cannabis space in Florida, where it oversees 11 dispensaries and is considered a "large player" in the regulated cannabis market, Burleson said in the Friday initiation note.

  • CNW Group

    Cansortium Comments on New Texas Law Enabling Access to Low-Level THC Cannabis Products for Texans Coping with Certain Chronic Medical Conditions

    MIAMI , June 18, 2019 /CNW/ - Jose Hidalgo , Founder and CEO of Cansortium Inc. ("Cansortium" or the "Company") (CSE:TIUM), a vertically-integrated, global provider of premium-quality medical cannabis operating under the Fluent™ brand, issued the following statement in response to Texas Governor Greg Abbott's signing of HB 3703 which expands access to low-level THC (less than 0.5%) cannabis products to benefit Texas residents coping with certain chronic medical conditions. "The Cansortium team is excited to work with the State of Texas to provide cultivation, processing and home delivery operations in Texas in order to bring the benefits of our premium-grade, low-level THC, cannabis products to Texas residents who are coping with chronic medical conditions.